Monopar Therapeutics, Inc. (MNPR)
63.00
-0.40
(-0.63%)
USD |
NASDAQ |
Jan 09, 16:00
62.76
-0.24
(-0.38%)
After-Hours: 20:00
Monopar Therapeutics Shareholders Equity (Quarterly): 141.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 242.22M |
| Electromed, Inc. | 44.74M |
| InfuSystem Holdings, Inc. | 55.47M |
| Xtant Medical Holdings, Inc. | 50.38M |
| VolitionRX Ltd. | -34.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.20M |
| Total Liabilities (Quarterly) | 2.639M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 56.10 |
| Net Debt Paydown Yield | -0.00% |